Trial site
Istanbul
- 9running trials
- 5closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- CIDP (chronic inflammatory demyelinating polyneuropathy)3 trials
- Asthma2 trials
- Haemophilia2 trials
- Bronchiectasis1 trial
- Chronic rhinosinusitis with nasal polyps1 trial
- COPD1 trial
- Cystic fibrosis1 trial
- Gastric and oesophageal cancer1 trial
- Hidradenitis suppurativa1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 38 trials
- Phase 25 trials
- Phase 41 trial
- Status
- Active, not recruiting5 trials
- Completed3 trials
- Recruiting3 trials
- Terminated2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Sanofi13 trials
- Bioverativ, a Sanofi company1 trial
Running trials
Recruiting
Recruiting
Enrolling by invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- CIDP (chronic inflammatory demyelinating polyneuropathy)2 recruiting
- Haemophilia1 recruiting
- Hidradenitis suppurativa1 recruiting
Closed trials
Completed
Completed
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Completed
Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma
Terminated
Terminated
Site data: ClinicalTrials.govUpdated 18 Nov 2026